Sebela Women's Health Inc.

This completed Phase 2 trial tested LevoCept, a levonorgestrel-releasing intrauterine system (IUD), for long-acting reversible contraception in 279 women aged 18-40. The study measured how well the IUD prevents pregnancy over 3 years, how easy it is to place, and its safety. Resu…

This Phase 2 study tested VeraCept, a copper intrauterine device (IUD), for long-acting contraception in 286 women aged 18-40. Researchers measured how well it prevents pregnancy and how easy it is to place. The results will help design a larger Phase 3 study.